Literature DB >> 19050176

Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.

Jonathan Q Purnell1, Steven E Kahn, Mary H Samuels, David Brandon, D Lynn Loriaux, John D Brunzell.   

Abstract

Controversy exists as to whether endogenous cortisol production is associated with visceral obesity and insulin resistance in humans. We therefore quantified cortisol production and clearance rates, abdominal fat depots, insulin sensitivity, and adipocyte gene expression in a cohort of 24 men. To test whether the relationships found are a consequence rather than a cause of obesity, eight men from this larger group were studied before and after weight loss. Daily cortisol production rates (CPR), free cortisol levels (FC), and metabolic clearance rates (MCR) were measured by stable isotope methodology and 24-h sampling; intra-abdominal fat (IAF) and subcutaneous fat (SQF) by computed tomography; insulin sensitivity (S(I)) by frequently sampled intravenous glucose tolerance test; and adipocyte 11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD-1) gene expression by quantitative RT-PCR from subcutaneous biopsies. Increased CPR and FC correlated with increased IAF, but not SQF, and with decreased S(I). Increased 11beta-HSD-1 gene expression correlated with both IAF and SQF and with decreased S(I). With weight loss, CPR, FC, and MCR did not change compared with baseline; however, with greater loss in body fat than lean mass during weight loss, both CPR and FC increased proportionally to final fat mass and IAF and 11beta-HSD-1 decreased compared with baseline. These data support a model in which increased hypothalamic-pituitary-adrenal activity in men promotes selective visceral fat accumulation and insulin resistance and may promote weight regain after diet-induced weight loss, whereas 11beta-HSD-1 gene expression in SQF is a consequence rather than cause of adiposity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050176      PMCID: PMC2645022          DOI: 10.1152/ajpendo.90769.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  47 in total

1.  The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men.

Authors:  T Ljung; G Holm; P Friberg; B Andersson; B A Bengtsson; J Svensson; M Dallman; B McEwen; P Björntorp
Journal:  Obes Res       Date:  2000-10

2.  Production rates of cortisol in obesity.

Authors:  Heinrich Vierhapper; Peter Nowotny; Werner Waldhäusl
Journal:  Obes Res       Date:  2004-09

3.  Rise in morning saliva cortisol is associated with abdominal obesity in men: a preliminary report.

Authors:  S Wallerius; R Rosmond; T Ljung; G Holm; P Björntorp
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

4.  Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.

Authors:  Jukka Westerbacka; Hannele Yki-Järvinen; Satu Vehkavaara; Anna-Maija Häkkinen; Ruth Andrew; Deborah J Wake; Jonathan R Seckl; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

5.  Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity.

Authors:  Deborah J Wake; Eva Rask; Dawn E W Livingstone; Stefan Söderberg; Tommy Olsson; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

Review 6.  11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.

Authors:  Jeremy W Tomlinson; Elizabeth A Walker; Iwona J Bujalska; Nicole Draper; Gareth G Lavery; Mark S Cooper; Martin Hewison; Paul M Stewart
Journal:  Endocr Rev       Date:  2004-10       Impact factor: 19.871

7.  Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women.

Authors:  Jonathan Q Purnell; David D Brandon; Lorne M Isabelle; D Lynn Loriaux; Mary H Samuels
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

8.  Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.

Authors:  Jeremy W Tomlinson; Jasbir S Moore; Penny M S Clark; Geoff Holder; Lynette Shakespeare; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.

Authors:  Stefan Engeli; Jana Böhnke; Mareike Feldpausch; Kerstin Gorzelniak; Ute Heintze; Jürgen Janke; Friedrich C Luft; Arya M Sharma
Journal:  Obes Res       Date:  2004-01

10.  Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss.

Authors:  Jeremy W Tomlinson; Joanne Finney; Beverly A Hughes; Susan V Hughes; Paul M Stewart
Journal:  Diabetes       Date:  2008-03-13       Impact factor: 9.461

View more
  44 in total

1.  Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study.

Authors:  Kai G Kahl; Wiebke Greggersen; Ulrich Schweiger; Joachim Cordes; Christoph U Correll; Helge Frieling; Chakrapani Balijepalli; Christian Lösch; Susanne Moebus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-07-10       Impact factor: 5.270

2.  The low-dose ACTH stimulation test: is 30 minutes long enough?

Authors:  Julia Cartaya; Madhusmita Misra
Journal:  Endocr Pract       Date:  2015-02-09       Impact factor: 3.443

Review 3.  Biological basis of depression in adults with diabetes.

Authors:  Shivam Champaneri; Gary S Wand; Saurabh S Malhotra; Sarah S Casagrande; Sherita Hill Golden
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

4.  Glucose ingestion selectively amplifies ACTH and cortisol secretory-burst mass and enhances their joint synchrony in healthy men.

Authors:  Ali Iranmanesh; Donna Lawson; Barbara Dunn; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

Review 5.  Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update.

Authors:  Kembra Albracht-Schulte; Nishan Sudheera Kalupahana; Latha Ramalingam; Shu Wang; Shaikh Mizanoor Rahman; Jacalyn Robert-McComb; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2018-02-27       Impact factor: 6.048

Review 6.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

7.  Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation.

Authors:  Naima Covassin; Fatima H Sert-Kuniyoshi; Prachi Singh; Abel Romero-Corral; Diane E Davison; Francisco Lopez-Jimenez; Michael D Jensen; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2018-05       Impact factor: 7.616

8.  Disparities in insulin resistance between black and white adults in the United States: The role of lifespan stress exposure.

Authors:  Thomas E Fuller-Rowell; Lydia K Homandberg; David S Curtis; Vera K Tsenkova; David R Williams; Carol D Ryff
Journal:  Psychoneuroendocrinology       Date:  2019-04-29       Impact factor: 4.905

Review 9.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

10.  Effects of proportions of dietary macronutrients on glucocorticoid metabolism in diet-induced obesity in rats.

Authors:  Roland H Stimson; Gerald E Lobley; Ioanna Maraki; Nicholas M Morton; Ruth Andrew; Brian R Walker
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.